Target intelligence / Profile preview

Huntingtin-interacting protein 1-related protein (HIP1R)

Target
HIP1R
Molecular classification
Endocytic adaptor protein, SLA2 family
01

Overview

Huntingtin-interacting protein 1-related protein (HIP1R) is an endocytic adaptor protein that belongs to the Sla2/HIP1 family, characterized by domains for binding clathrin, inositol lipids, and F-actin[1][7]. HIP1R contains an AP180 N-terminal homology (ANTH) domain, a central coiled-coil region for clathrin light-chain binding, and a C-terminal THATCH domain for F-actin linkage[7]. It is ubiquitously expressed, especially in the brain, and is localized to clathrin-coated pits and vesicular structures, where it coordinates membrane trafficking and cytoskeletal dynamics during endocytosis[6][2]. HIP1R plays an important role in neural development, dendritic branching, and excitatory synapse formation; knockdown in primary neurons selectively impairs dendrite growth, glutamate receptor expression, and excitatory transmission[1][7]. Mechanistically, HIP1R stabilizes receptor tyrosine kinases such as EGFR after ligand-induced endocytosis and supports survival signaling[6][7]. Although HIP1R is structurally related to huntingtin-interacting protein 1 and does not interact directly with huntingtin or have a defined role in Huntington’s disease, genetic studies highlight its importance in neurobiology and other developmental processes[1][2][4]. No drugs currently target HIP1R directly, and no known clinical biomarkers or safety data exist for therapeutic manipulation of this protein.

Other names
HIP1RHIP12KIAA0655HIP1-related proteinHIP-12HIP3FLJ14000ILWEQHuntingtin-interacting protein 12huntingtin-interacting protein 1-related protein
02

Mechanism of action

Not therapeutically targeted; mechanistically, HIP1R regulates endocytosis, stabilizes receptor tyrosine kinases (e.g., EGFR) following ligand-induced endocytosis[7], links actin cytoskeleton to clathrin-coated vesicle formation[6][3]

03

Biological functions

EndocytosisActin cytoskeleton remodelingProtein stabilizationCell survivalDendritic growthExcitatory synapse formationSignal transduction
04

Disease associations

Neurodevelopmental disordersSimpson-Golabi-Behmel Syndrome[2]Potential relevance in synaptic dysfunctionOther (no direct evidence in neurodegenerative diseases like Huntington’s disease[1])
05

Safety considerations

Not applicable; not currently a direct therapeutic target—knockdown affects neuron development and synapse formation[1], but no known toxicity or safety data as a drug target

Beyond the preview

Go deeper on Huntingtin-interacting protein 1-related protein (HIP1R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huntingtin-interacting protein 1-related protein (HIP1R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call